Orgenesis Inc. (ORGS) Social Stream

Orgenesis Inc. (ORGS): $2.30

0.00 (0.00%)

POWR Rating

Component Grades













Orgenesis Inc (ORGS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ORGS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-06-18 1 $9 $9 $9 $3.39 165.49%

Price Target Last Issued June 18, 2021

The Trend in the Analyst Price Target

Over the past 135 days, ORGS's average price target has gone down $0.

ORGS reports an average of 76.29% for its upside potential over the past 170 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-22 0 9 9 9 5.17 74.08%
2021-06-05 0 9 9 9 5.65 59.29%
2021-07-03 1 9 9 9 5.00 80%
2021-09-18 1 9 9 9 5.08 77.17%
2021-09-19 1 9 9 9 5.08 77.17%

ORGS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORGS as an investment opportunity.

  • In terms of how Orgenesis Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
  • To contextualize these metrics, consider that out of all US stocks, Orgenesis Inc's variance in analysts' estimates is lower than just about 100% of them.
  • In the context of Healthcare stocks, Orgenesis Inc's average analyst price target is higher than 13.43% of them.
  • In the context of stocks in the micro market cap category, Orgenesis Inc's upside potential (average analyst target price relative to current price) is higher than 40.75% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Orgenesis Inc are ONCS, OGEN, and NRBO.

Is ORGS a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6122 seconds.